Pituitary hormones
Pituitary hormone medicaments in measured doses
HSN 3004 39 11 (Pituitary hormones) is subject to Central Drugs Standard Control Organisation (CDSCO) drug registration and import licensing under the Drugs and Cosmetics Act, 1940. The Directorate General of Foreign Trade (DGFT) classifies the import of oxytocin as prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022, with a narrow carve-out for oxytocin reference standards imported exclusively for test and analysis against a DGCI/CDSCO test licence.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Batch release certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade.
- 1Obtain a valid drug registration certificate (document code 101dc1) and import licence for drugs (document code 9111dc) from the Central Drugs Standard Control Organisation before shipment. Both documents must be uploaded in e-Sanchit prior to filing the bill of entry; customs out-of-charge will not be granted without verified upload.Drugs and Cosmetics Act, 1940 · document codes 101dc1 and 9111dc
- 2Upload the Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (document code 0030dc), and Label of Consignment (document code 0110dc) in e-Sanchit at the bill of entry stage. The proper officer is required to verify all five mandatory documents before granting out-of-charge on PGA-facilitated bills.CDSCO e-Sanchit document codes 0010dc, 0030dc, 0110dc
- 3If the specific pituitary hormone being imported is oxytocin, confirm the consignment is restricted to reference-standard quantities for test and analysis only, supported by a test licence issued by DGCI/CDSCO. General commercial import of oxytocin is prohibited under S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022.S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
The most common error on this tariff line is conflating the blanket oxytocin prohibition with the residual pituitary-hormone regime: importers shipping oxytocin under a standard CDSCO drug import licence — without a specific DGCI/CDSCO test licence and a reference-standard end-use justification — face confiscation and prosecution, not merely detention. The MEFCC O.M. dated 15-12-2023 also imposes separate conditions on high-value used or refurbished medical equipment; verify that this entry point does not inadvertently cover any such equipment falling under that O.M.